Purple Biotech Ltd (TLV:PPBT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
4.200
+0.300 (7.14%)
May 8, 2025, 2:08 PM IDT

Purple Biotech Market Cap

Purple Biotech has a market cap or net worth of 22.62 million as of May 8, 2025. Its market cap has decreased by -65.74% in one year.

Market Cap
22.62M
Enterprise Value
-7.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.20

Market Cap Chart

Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 22.62M, an increase of 26.53%. That is a compound annual growth rate of 2.01%.

History

DateMarket Cap% Change
May 7, 202522.62M-43.93%
Dec 31, 202440.34M-48.30%
Dec 31, 202378.02M-17.30%
Dec 29, 202294.35M-55.64%
Dec 30, 2021212.71M-1.36%
Dec 31, 2020215.65M332.51%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 31, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Teva Pharmaceutical Industries 72.49B
Danel (Adir Yeoshua) 2.32B
Kamada 1.42B
Bait Bakfar 1.16B
Novolog (Pharm-Up 1966) 785.68M
Ilex Medical 683.37M
SofWave Medical 622.52M
BrainsWay 593.22M
Market Cap Rankings